ࡱ> )` Rbjbj{{P>)  lLlLlL8L,M JNN(NNNPP PEGGGGGG$h6:k WP"PWWk NN^^^W N NE^WE^^bٴ$ INN jlL5[$V10JSpY\lpIp IPR0^STPPPkk]XPPPJWWWW d$ d%1 $ 1  Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.q\qge兡N gPlQSShandong Xinhua Pharmaceutical Company Limited(a joint stock company established in the People s Republic of China with limited liability)(Stock Code: 0719)CONTINUING CONNECTED TRANSACTIONSThe Board announces that on 27 October 2014, the Company entered into (1) the 2014 Supplemental Trademark Licence Agreement with SXPGC and (2) the China Shandong Agreement with China Shandong.A. 2014 Supplemental Trademark Licence AgreementReference is made to the announcements of the Company dated 28 October 2009 and dated 23 March 2012.On 27 October 2014, the Company and SXPGC entered into the 2014 Supplemental Trademark Licence Agreement. Pursuant to the 2014 Supplemental Trademark Licence Agreement, the annual licence fees payable by the Company for using the Trademark are RMB10,000,000 for each of 2015, 2016 and 2017and the annual licence fees shall be paid by the Company to SXPGC on or before 30 June of each of 2015, 2016 and 2017.Other terms of the Trademark Licence Agreement remain unchanged. The 2014 Supplemental Trademark Licence Agreement will come into effect on 1 January 2015 and will expire on 31 December 2017. It is a term of the 2014 Supplemental Trademark Licence Agreement that each of the Company and SXPGC is entitled to terminate the 2014 Supplemental Trademark Licence Agreement by a three months written notice in advance.As at the date of this announcement, SXPGC holds 35.32% equity interest of the Company and is a substantial shareholder of the Company. Therefore, SXPGC is a connected person under the Listing Rules. The transactions contemplated under the 2014 Supplemental Trademark Licence Agreement will constitute continuing connected transactions under Chapter 14A of the Listing Rules.The annual cap under the 2014 Supplemental Trademark Licence Agreement for each of 2015, 2016 and 2017 will be RMB 10,000,000. Since the applicable percentage ratios (as defined in the Listing Rules) are less than 5% on an annual basis, the continuing connected transactions contemplated under the 2014 Supplemental Trademark Licence Agreement are only subject to the reporting, announcement and annual review requirements, but exempt from the Independent Shareholders approval requirement under Chapter 14A of the Listing Rules.B. Continuing connected transactions between the Company and China ShandongOn 27 October 2014, the Company also entered into the China Shandong Agreement with China Shandong in relation to the Company and/or its subsidiaries supplying bulk pharmaceuticals and chemical products to China Shandong commencing on 1 January 2015 and expiring on 31 December 2017, which is terminable by each party upon a three months written notice in advance. As at the date of this announcement, China Shandong is a subsidiary of HHGC. HHGC is a substantial shareholder of the Company and holds 35.32% equity interest of the Company through its wholly owned subsidiary, SXPGC. Accordingly, China Shandong, being an associate of HHGC, is a connected person of the Company and the transactions contemplated under the China Shandong Agreement constitute continuing connected transactions under Chapter 14A of the Listing Rules. The highest annual cap for 2015, 2016 and 2017under the China Shandong Agreement is RMB80,000,000. Since the applicable percentage ratios (as defined in the Listing Rules) are less than 5% on an annual basis, the continuing connected transactions contemplated under the China Shandong Agreement are only subject to the reporting, announcement and annual review requirements, but exempt from the Independent Shareholders approval requirement under Chapter 14A of the Listing Rules .The Board announces that on 27 October 2014, the Company entered into (1) the 2014 Supplemental Trademark Licence Agreement with SXPGC and (2) the China Shandong Agreement with China Shandong.2014 SUPPLEMENTAL TRADEMARK LICENCE AGREEMENTA. Background InformationReference is made to the announcements of the Company dated 28 October 2009 and 23 March 2012. On 7 December 1996, the Company and SXPGC entered into the Trademark Licence Agreement pursuant to which the Company was granted by SXPGC the exclusive right to use the Trademark for its existing and future products in and outside the PRC for an indefinite period as long as the PRC registration of the Trademark continues to be valid and the Company continues to use the Trademark. On 23 March 2012, the Company and SXPGC entered into the 2012 Supplemental Trademark Licence Agreement which amends and supplements the Trademark Licence Agreement. Pursuant to the 2012 Supplemental Trademark Licence Agreement, the Company was granted by SXPGC the exclusive right to use the Trademark for the period between 1 April 2012 and 31 December 2014.BContinuing connected transactions between the Company and SXPGCPrincipal terms of the 2014 Supplemental Trademark Licence AgreementDate : 27 October2014Parties : (i) the Company (ii) SXPGCOn 27 October2014, the Company and SXPGC entered into the 2014 Supplemental Trademark Licence Agreement amending and supplementing the Trademark Licence Agreement as amended by the 2012 Supplemental Trademark Licence Agreement. Pursuant to the 2014 Supplemental Trademark Licence Agreement, the annual licence fees payable by the Company for using the Trademark will be RMB10,000,000 for each of 2015, 2016 and 2017and the Company shall pay the annual licence fees to SXPGC on or before 30 June of each of 2015, 2016 and 2017.Other terms of the Trademark Licence Agreement remain unchanged.The 2014 Supplemental Trademark Licence Agreement will come into effect on 1 January 2015 and will expire on 31 December 2017, and each of the Company and SXPGC is entitled to terminate the 2014 Supplemental Trademark Licence Agreement by a three months written notice in advance.Basis upon which the caps is determinedIn determining the caps, the Company has taken into consideration of the following factors:the branding effect of the Trademark; and the sales scale of the products that uses the Trademark. Reasons for and benefits of the continuing connected transactions between the Company and SXPGCBy virtue of the Trademark Licence Agreement as amended and supplemented by the 2012 Supplemental Trademark Licence Agreement and the 2014 Supplemental Trademark Licence Agreement, the Company and/or its subsidiaries will be able to continue to use the Trademark on marketing and the current and future production of its products in and outside the PRC which is essential for the continued running of the Company. The Directors (including the independent non-executive directors of the Company) consider that:the entering into the 2014 Supplemental Trademark Licence Agreement is in the interest of the Company and its Shareholders as a whole; the continuing connected transactions contemplated under the 2014 Supplemental Trademark Licence Agreement are on normal commercial terms and in the ordinary and usual course of business; and the terms of the continuing connected transactions contemplated under the 2014 Supplemental Trademark Licence Agreement are fair and reasonable.None of the Directors have a material interest in the continuing connected transactions under the 2014 Supplemental Trademark Licence Agreement and therefore no Director is required to abstain from voting on the board resolution in relation to the continuing connected transactions under the 2014 Supplemental Trademark Licence Agreement.Connected RelationshipAs at the date of this announcement, SXPGC holds 35.32% equity interest of the Company and is a substantial shareholder of the Company. Therefore, SXPGC is a connected person under the Listing Rules. The transactions contemplated under the 2014 Supplemental Trademark Licence Agreement will constitute continuing connected transactions under the Listing Rules. Implications under the Listing RulesThe annual cap for each of 2015, 2016 and 2017 under the 2014 Supplemental Trademark Licence Agreement will be RMB 10,000,000. Since the applicable percentage ratios (as defined in the Listing Rules) are less than 5% on an annual basis, the continuing connected transactions contemplated under the 2014 Supplemental Trademark Licence Agreement are only subject to the reporting, announcement and annual review requirements, but exempt from the Independent Shareholders approval requirement under Chapter 14A of the Listing Rules. CHINA SHANDONG AGREEMENTC. Continuing connected transactions between the Company (including its subsidiaries) and China ShandongPrincipal termsof the China Shandong AgreementDate : 27 October 2014Parties : (i) the Company (ii) China ShandongOn 27 October 2014, the Company and China Shandong entered into the China Shandong Agreement in relation to the Company and/or its subsidiaries supplying bulk pharmaceuticals and chemical products to China Shandong.The term of the China Shandong Agreement runs from 1 January 2015 to 31 December 2017 and each of the Company and China Shandong is entitled to terminate the China Shandong Agreement by a three months written notice in advance. Payment termsThe prices of the bulk pharmaceuticals and chemical products are based on market prices and will be stated in the sales order of each transaction. Payment should be settled within the time limit based on the prices stated in the sales order of each transaction. Annual capsThe annual caps for the China Shandong Agreement are as follows:-2015(RMB 000)2016(RMB 000)2017(RMB 000)Annual caps65,00072,00080,000The Company has determined the above annual caps based on the following factors:-the projected demand by China Shandong; andthe projected increase in the market prices of chemical raw materials for the production of the bulk pharmaceuticals. It is estimated that:China Shandongs demand in 2016 may have an approximately 10% increase compared with its demand in 2015; andthe market prices of chemical raw materials may have an approximately 10% increase in 2017 compared with that in 2016. Reasons for and benefits of the continuing connected transactions between the Company and China ShandongBy virtue of the China Shandong Agreement, the Group will be able to increase its revenue by selling the bulk pharmaceuticals and chemical products to China Shandong and expand the global sale of the Groups products. Accordingly, the Directors (including the independent non-executive Directors) consider that:the entering into the China Shandong Agreement is in the interest of the Company and its Shareholders as a whole; the continuing connected transactions contemplated under the China Shandong Agreement are on normal commercial terms and in the ordinary and usual course of business of the Group; and the terms of the continuing connected transactions contemplated under the China Shandong Agreement are fair and reasonable.None of the Directors has a material interest in the continuing connected transactions and therefore no Director is required to abstain from voting on the board resolution in relation to the continuing connected transactions under the China Shandong Agreement.Connected RelationshipAs at the date of this announcement, China Shandong is a subsidiary of HHGC. HHGC is a substantial shareholder of the Company and holds 35.32% equity interest of the Company through its wholly owned subsidiary, SXPGC. Accordingly, China Shandong, being an associate of HHGC, is a connected person of the Company and the transactions contemplated under the China Shandong Agreement constitute continuing connected transactions under Chapter 14A of the Listing Rules.Implications under the Listing RulesThe highest annual cap for 2015, 2016 and 2017under the China Shandong Agreement is RMB80,000,000. Since the applicable percentage ratios (as defined in the Listing Rules) are less than 5% on an annual basis, the continuing connected transactions contemplated under the China Shandong Agreement are only subject to the reporting, announcement and annual review requirements, but exempt from the Independent Shareholders approval requirement under Chapter 14A of the Listing Rules.D. Information about the Company, SXPGC and China Shandong The Company is mainly engaged in the development, manufacture and sales of bulk pharmaceuticals, preparations and chemicals products.SXPGC is a state-owned enterprise established in the PRC specialising in investment in the pharmaceutical industry, and associated chemical production, packaging and supply of chemical engineering equipment.China Shandong is principally engaged in import and export trading business. E. DefinitionsIn this announcement, the following expressions have the meanings set out below unless the context requires otherwise:2012 Supplemental Trademark Licence Agreement2014 Supplemental Trademark Licence AgreementBoardChina ShandongChina Shandong Agreementmeans the supplemental trademark licence agreement dated 23 March 2012 entered into between the Company and SXPGC amending and supplementing the Trademark Licence Agreement;means the supplemental trademark licence agreement entered into between the Company and SXPGC on 27 October 2014;means the board of Directors of the Company;means oƖW gPlQS (China Shandong Group Ltd.), a subsidiary of HHGC;means the written agreement entered into between the Company and China Shandong on 27 October 2014 in relation to the Company and/or its subsidiaries supplying bulk pharmaceuticals and chemical products to China Shandong; Company means q\qge兡N gPlQS (Shandong Xinhua Pharmaceutical Company Limited), a joint stock company incorporated in the PRC with limited liability; Directors  Group  HHGC means the directors of the Company including the independent non-executive directors of the Company;means the Company and its subsidiaries;means ocƖW gPlQS (Hualu Holdings Group Company Limited), a wholly state-owned company, the controlling shareholder of SXPGC;Independent Shareholdersmeans the Shareholders other than SXPGC and its respective associates (as defined in the Listing Rules);Listing Rulesmeans the Rules Governing the Listing of Securities on the Stock Exchange;PRC means the Peoples Republic of China;RMB means Renminbi, the lawful currency of the PRC for the time being;Trademarkmeans the trademark Xinhua;-p q r s u   v x 0 4 X Z \ кvlaWJBh\Ohqjo(h*h}X0PJnHtHh}X0PJnHtHh}X05PJnHtHh+Wh}X05o(h}X0h}X0PJnHtHh+WPJnHtHhF6]o( hFCJhFCJo( hFo(hFnHtH hF6]hF*jh}'h}'6U]mHnHtHuh9%hw=x5CJOJQJ"h9%hw=x6KHOJPJQJ]h9%hw=x6KHOJQJ]q s t u v  x 2 4 Z \ ,-$G$IfVD^gd* $G$H$Ifgd*G$H$gd}X0$a$gd}X0 $G$H$a$gd+WG$H$$G$H$a$G$H$gdw=x   M N R X ] a e s } ~ +,-.0:Ÿۄufb]Uh*ho( ho(hh*hjTKHPJnHtHhjThjTKHPJnHtH hjTo(h}X0KHPJnHtH"hAh}X05KHPJ\nHtHh6=hA5h5KH\h*h}X05KH\o(h*h}X05KH\h\OheMKH\hHPJo( h\OhAh\OhAo(h\Ohqjo( h\Ohqj :<>@BEPVhm   /3Nhiz{ 9NνĴĚĚĚĚĴĚĴ}ph@hZhPJnHtHh, h}X0o(h}X0h*h?KHo( h?KH h ]KHhbiKHo(hHKHPJnHo(tHh*h}X0KHhqjKHo(h*h}X0KHo(h*h}X0KHnHo(tHh}X0nHo(tHhnHtHh*ho(h hsZh,-de?@$7$7$8$H$If^7a$gd*$$7$8$G$H$Ifa$gd*$$7$8$H$Ifa$gd*$$7$8$G$H$Ifa$gd* $Ifgd}X0$G$IfVD^gd* $Ifgd}X0$$G$H$Ifa$gd*NORT[atGHWbcde-UZŵ{paahdKHPJaJnHo(tHh*hT KHaJh,KHaJhY~|KHaJo(h*h}X0KHaJ#h*h}X0KHPJaJnHo(tHh*h}X0KHaJo(h*h}X0KHaJnHo(tHh*h}X0PJnHtHh._htfPJo(h h o( h?o(h? h}X0o(h}X0hHPJo(&$)1L]d69:WXewɹwwh\hMwwhhdKHPJaJnHo(tHh,KHaJnHtHh*hPKHaJnHtHh*hT KHaJnHtHhxKHaJnHtHh ]KHaJnHtHhVPKHPJaJnHo(tHh?KHaJnHtHh*h}X0KHaJnHo(tHh*h}X0PJnHtH h*h}X0KHPJaJnHtHh*h}X0KHaJo(h*h(KHaJo(/>?@ACMOQSU`e´vjb^YQJ^Q^EAh( h}X0o( hsZh?h*h?o( h?o(h?h}X0nHtHh*h}X05KH\h*h}X05KH\o(h*hP5KH\nHtH!h*h}X05KH\nHo(tHh*h}X05PJnHo(tHh*h}X05PJnHtHh*h}X0KHaJnHtHh*h}X0KHaJnHo(tHh*hPKHaJnHtHhdKHPJaJnHo(tHerv$'+-4:CFJp~9:<=XY̼wiwih*h}X0PJnHo(tHh}X0nHo(tHh}X0nHtHh*hPKHaJ#h*h}X0KHPJaJnHo(tHh*h}X0KHaJh*h}X0KHaJo(h*h}X0KHaJnHo(tHh*h}X0PJnHtHhxh}X0 h(o(h(hdPJo( hbio(hbi h}X0o()yz'(=efghi;vvib h*h}X0h*h}X0PJnHtHh*h}X0KHaJnHtHhdKHPJaJnHo(tHhdPJnHo(tHh*hPKHaJnHtHh*h}X0KHaJnHo(tHh*hKHaJnHtHhnHtHh*hCPJnHo(tH h}X0o(h*h}X0PJnHo(tHh}X0nHo(tH!ghij+,Z[um___P$7$8$G$H$`a$$7$8$G$H$a$gd6=G$H$gd}X0nkd$$Ifl2"" t0644 lap yt* $G$H$Ifgd*$$G$H$Ifa$gd*ij )+,YZ[^_uvwĴ}yti_tityh(PJnHtHh%PJnHo(tH hFo(hF hF5\hF5\o(h@j5PJ\nHtHh%5PJ\nHo(tHh(5PJ\nHtHh6=h6=5PJ\nHtHh}'h}'5h6=hdPJnHo(tHh( hsZh(h*h(o( h(o(h}X0h}X0PJnHtH#[vwYZ>@tv$77$8$G$H$^7a$gd($77$8$G$H$^7a$gd($77$8$G$H$^7a$gd($7$8$G$H$VD^a$gd($7$8$G$H$a$gd6=$7$8$G$H$a$gd(XZ[]_`egij{<>辷ԷzԷsffhB>KHPJnHo(tHh2KHo(hY~|KHPJnHo(tH h2KHhdKHPJnHo(tH h6=hB>h"PJnHo(tHh" hsZh"hB>KHo(hB>KHnHo(tHhB> hsZhB>hY~|PJnHo(tHhB>nHo(tHhB>PJnHo(tHhFKHo( hFKH' DF "$&ȽrgZM@hdKHPJnHo(tHh@aKHPJnHo(tHhsZKHPJnHo(tHhFKHnHo(tHh6=hF5KHnHtHh6=h,56KHh6=hF56KH hF5\hB>hB>KHPJnHtH hP5\hB>5\o(hB>hB>5\o("hB>hB>5KHPJnHo(tHhFKHPJnHtHhB>KHPJnHo(tHhB>KHo( hB>KH&4:<>@NPRTrvz|~ 7 : I L l m o ͫͫ|q㫤gaaa h2KHh,KHnHtHhdPJnHo(tHhsZPJnHo(tHhdKHPJnHo(tH hFKHh@jKHnHtHhFKHo(hFKHnHo(tHhF5KH\o(h6=hFPJnHtHhFKHnHtHhFKHPJnHtHh@aPJnHo(tH hFo(h6=h@aPJnHtH%v""4#5#]#^#####$7$8$G$H$a$gd($ & F'Z7$8$G$H$^Z`a$gd6=$7$8$G$H$VD^a$gd($7$8$G$H$a$gd($7$8$G$H$^a$gd($7$8$G$H$a$gd6= o z !!!!!!!"!%!4!;!J!N!i!y!~!!!!!!!!""""#"L"a"e"g"o"r"s"t""""""ɼϰϰɰɰɬ϶ϰɡϔ h KHh KHPJnHtHhO[KHPJnHo(tH hO[KH hFo(hF hKH h,KHhhKHPJnHo(tH hFKHhFKHo(h*hKHo( h6=hhdKHPJnHo(tH hKH h@jKH2"""""##'#2#3#5#M#N#\#]#^#t#u###########$$ $!$"$b$c$$$Źűإثثث؜vj_hF5KH\aJh6=hP56KHh6=hF5KHPJnHtHhaPB*KHphhFB*KHo(phh6=hFKH hKH hFKHh6=hF6h6=h56KHh6=hF56KH h6=hFhFKHo( h@jKHhhKHPJnHo(tH h KHh KHo($#!$"$$$&& ' '''^(_()}$7$8$G$H$a$gd($77$8$G$H$^7a$gd($ & F(>7$8$G$H$^`>a$gd6=$7$8$G$H$a$gd6=$7$8$G$H$VD^a$gd($ & F'Z:7$8$G$H$^Z`:a$gd6=$$$$%% %%%%,%D%[%\%%%&!&0&9&&&&&&&&' ' '/'0'='H'M'b'v'}u}}m}e}u}hPKHaJhFKHaJh,KHaJhFKHaJo(hFKHaJnHo(tH hFKHhFKHaJhOKHaJo(hFKHaJh1KHaJo(h1KHo( h6=hFh,KHaJhdKHPJnHo(tHh*haPKHo( haPKHhX^KHaJhFKHaJo(#v'y'z''''''''''((((\(](^(_(u(w(y(z((((((((ϻϳêvlbvYQhX^KHaJhX^KHaJo(hPB*aJphhFB*aJph"h1B*PJaJnHo(phtHhX^B*aJphhX^B*aJo(phhFB*aJo(phh,hFKHh,KHaJhPKHaJhFKHaJnHtHhFKHaJo(hFKHaJnHo(tHh1KHPJaJnHo(tHhkTKHaJnHtH(((((W)l)w)x)))))))))))))**7*B*S*t**¸̡vm^mOmHH h6=h~hFKHPJaJnHo(tHhqE3KHPJaJnHo(tHhFKHaJo(hFKHaJnHo(tHhFnHtHhhF5\h6=hF56KHhFPJnHtHhCaJo( hCaJhCB*aJphhPB*aJphhFB*aJph h6=hFhFB*aJo(phhX^KHaJo(hX^KHaJnHo(tH))))5+6+[+\+p-q-----%.&.=.>.X.$77$8$G$H$^7a$gd( >^`>gd6=$7$8$G$H$a$gdX^$7$8$G$H$a$gd6=$77$8$G$H$^7a$gd(****+++ +4+5+6+[+\+j+n+o++++++++++++,,$,-,1,G,H,m,n,Ƹyrj_j[hPhFPJnHo(tHhnHtHhFKHo(hX^nHtHh,nHtH hCKHh1PJnHo(tH hFo(hFnHo(tHhFh6=hF56KHhhF5KH\aJhFKHaJh1KHPJaJnHo(tHhPKHaJh,KHaJhFKHaJo(h~KHaJo(#n,,,,,,,,,,----0-1-F-G-m-o-p-q----------ɻ~og`gY hqE35\ hP5\hqE35\o(hX^5KHPJaJnHtH&hqE3hqE35KHPJaJnHo(tHh6=KHPJaJnHtH h6=h6=KHPJaJnHtHh6=h6=5KHhqE3KHPJaJnHtHhFKHPJaJnHtHhKHaJnHtHhFh1PJnHo(tHhh ] hFo(--. .%.&.*.-.../.0.7.;.<.=.>.E.F.G.H.W.Y.[.\.a.o.ƻrhaVLVBVahX^KHnHtHhqE3KHnHtHhqE3KHnHo(tHhqE3KHo(h6=hqE3KH\hX^hqE3KHnHtHhX^hqE3KHPJnHtHhdPJnHo(tHhX^hcPJnHtH hX^hqE3hhqE3KHnHo(tHh6=hqE3nHtHh6=hqE35KHnHtHh6=hqE356KHh6=56KHh6=h6=56KHh6=hqE36KHX.Y.p.q.I/J/0010?0@000I1J1V1W1$77$8$G$H$^7a$gd($ & F 7$8$G$H$^a$gd6=$77$8$G$H$^7a$gd($7$8$G$H$^a$gd($7$8$G$H$a$gd6=$77$8$G$H$^7a$gd(o.p.q.t.u.v.w.~........../ ///,/5/9/G/H/J/Z/_/h/}/~//////////00"0-0/000Ჩᘿэ܍эvhchqE3KHnHtH hX^KHhchY*^PJnHo(tH h6=hqE3hqE3KHnHtHhqE3nHo(tH hqE3o(hqE3nHtHhqE3KHo(h1PJnHo(tHhcPJnHo(tH hco(hqE3KHnHo(tHh6=hqE35KHnHtH hqE3KH.0010>0?0@0I0J0R0W0e0s0|0}0000 11H1J1K1U1V1W1o111111111111Ŧךᒷ{ma{{h_hqE35PJ\h_5PJ\nHo(tHhqE35\nHo(tHhqE35\nHtHhqE3nHtHh6=h\o56KH hqE3KHh1PJnHo(tHhqE3nHo(tH hqE3o(hqE3KHo(hqE3KHnHo(tHhqE3KHnHtHh6=hqE36h6=hqE356KHh6=hqE36KH#W1111111111$$7$8$G$H$Ifa$gd($$7$8$G$H$Ifa$gd($87$8$G$H$^8a$gd($7$8$G$H$a$gd6= 1111111111111111111111111112оНwl_l_l_[OHhqE3aJo(hqE3KHaJnHtHhCh'dhCPJnHtHhCPJnHo(tHhC5\nHtHhC5\nHo(tHh\o5\nHtHhqE3hqE35\mHnHtHu%h_hqE35PJ\mHnHtHu hqE35\hqE35\nHtHhqE35\nHo(tHh_hqE3PJnHtHh_5PJ\nHo(tHhqE35\o(111111eSAAA$$7$8$G$H$Ifa$gd($$7$8$G$H$Ifa$gd(kd$$Ifq\ L  064qayt6=111A2B2eK=48^8gd($7$8$G$H$a$gd6=$\7$8$G$H$VDWDQ^`\a$gd6=kdI$$Ifq\ L  064qayt6=22@2B2Y2Z2h2m2o2r2}222222222222222 33333"3&3)393:3d3e3j3ŹŹŹᜱ~og_h6=KHaJhCKHaJhqE3KHPJaJnHo(tHho(KHPJaJnHo(tHh!KHPJaJnHo(tHhqE3KHPJaJnHtH h6=hqE3hqE3KHaJhqE3KHaJnHtHhqE3KHaJnHo(tHh1KHPJaJnHo(tHhqE3KHaJo( hqE3aJhqE3aJo(hhqE3o(%B2n2o22222k3l333N4yyk$7$8$G$H$a$gd($ & F%vv7$8$G$H$^v`a$gd6=$n7$8$G$H$a$gd($7$8$G$H$a$gd6=$n7$8$G$H$VD^a$gd($Z7$8$G$H$^Za$gd6=$ & F vv7$8$G$H$^v`a$gd6= j3l333333333333%4&4N4O4P4Q4R444444444445ƺzululaZ h6=hqE3h1PJnHo(tHhqE3nHo(tH hqE3o(hCKHaJh1KHPJaJnHo(tHhqE3KHaJhqE3KHaJo(hqE3KHaJnHtHh6=hP56KHh6=hqE356KHh6=hqE36KHh!KHPJaJnHo(tHh6=KHaJhCKHaJhqE3KHaJo(hqE3KHaJN4O455556627378898P8Q8#:$:$77$8$G$H$^7a$gd($7$8$G$H$a$gd(!gd6=$ & F$vv7$8$G$H$^v`a$gd6=$77$8$G$H$^7a$gd($7$8$G$H$a$gd6=$7$8$G$H$VD^a$gd(5 5554575D5E5G5m5n5x5555555555 6!6.6G6H6U666666666żŐżżyqżeYhqE3KHaJnHtHhCKHaJnHtHhPKHaJhqE3KHaJh1KHPJaJnHo(tHhqE3KHPJaJnHtHhqE3KHPJaJnHo(tHh!KHPJaJnHo(tHhqE3KHaJo(hqE3KHaJnHo(tHhqE3KHaJnHo(tHhqE3KHaJhqE3KHaJo(hqE3KHPJaJnHo(tH"66667707172737h7}7777778888,8-868788898O8P8Q8v8¶΂xlbZMhqE3KHaJnHo(tHhqE3nHtHhhqE35\h6=hqE356KHhqE3PJnHtHhCKHaJo(hCB*aJphh6=h\oKHaJh\oB*aJphh\oB*aJo(phh\oKHaJnHtHhqE3KHaJnHtHh1KHPJaJnHo(tHhPKHaJnHtHhqE3KHaJnHo(tHhqE3KHaJo(v888888899":#:$:I:J:h:i:n:o:t:w:x:::::::::::;;;?;zn^R^hnhyKHaJo(hnhyKHaJnHo(tHhKHaJnHtHhnHtHhEePJnHo(tHh6=hqE3KHaJh1PJnHo(tH hqE3o(hPJnHo(tHhqE3nHo(tHhqE3h6=hqE356KHhqE35KH\aJhPKHaJhKHPJaJnHo(tHhqE3KHaJhqE3KHaJo( $:I:J:,<-<j<k<<<==>>!>">>>7$8$G$H$ 6VD^6gd6=$7d^7`gd($77$8$H$^7a$gd( >^`>gd6=$77$8$G$H$^7a$gd($7$8$G$H$a$gd6=?;@;X;f;p;q;t;;;;;;;;;;;<*<+<,<-<0<1<N<P<U<Y<i<˿俰䝕sh\sThqE35\o(hkT5KH\aJo(hkT5KH\aJhqE35KH\aJo(hbx5KH\aJh+f5KH\aJhqE3KHaJhqE3hnhyKHaJnHtHh1KHPJaJnHo(tHhKHaJnHtHh1PJnHo(tHhynHo(tH hyo(hnhyKHaJnHo(tHhPKHaJnHtHi<j<k<<<<<<<<<<<<+=7======>>>>> >㬢wjwj`UGh6=hF5KH\aJhbx5KH\aJh6=hqE36KHhqE3KHaJnHo(tHhqE3KHaJo(h6=hkTnHtH hkTaJhkTKHaJhkTKHaJo(hqE3PJnHtHhqE3CJKHOJPJaJh1KHPJaJnHo(tHh6=hqE3KHaJhqE3KHPJaJnHo(tHhqE3KHPJaJhqE3KHaJhqE35KH\aJ >!>">*>6>x>y>>>>>>>>>??????)?2?3?5?h?n?o?p?q?v?|???Ⱦȸ枔|ȸocVcȸho(KHPJnHo(tHhjTKHPJnHtHhjTKHPJnHo(tHh6=hk 5KHnHtHhk KHnHtHh6=hk 5KH hk KHh6=hF5KHh6=hjT5KH hjTKHh6=h"5KH h"KHhKHPJnHo(tHhhFKHaJ hFKHhF5KH\aJh6=hFaJ!>>>>>>?????4?5???@@A AAALCNC$$7$8$G$H$Ifa$gd0O$$7$8$G$H$Ifa$$7$8$G$H$IfgdjT $7$8$G$H$If???@@@@@@@AA AAAB.B0B6B8B:BHIJKLSWXcdew{ǼӼ&+@BCpvwµ®¥ܘrrrgg`r`X`h9%hHo( h9%hHhHPJnHo(tHh9%hHPJnHo(tHh6=hHKHaJh9%hHPJnHtHhHhFPJnHtHhFKHaJo(hFKHo(h1KHPJnHo(tHhyKHPJnHo(tHhK]KHPJnHo(tHhFKHaJhF6KH]aJhF5KH\aJnHo(tH HIdeӼ'AB$$G$Ifa$gd4/q $G$a$gdH$7$8$G$H$a$gd6=$G$a$ $7$8$G$H$a$BC]lwOMQkds$$If0!644 ayt4/q$$G$Ifa$gd4/qQkd$$If0!644 ayt4/q hkCJhk0JmHnHu hk0Jjhk0JUhk hk6]hNrjhNrU hHhF$4$a$&`#$$a$10:p+W/ =!"#$n% nu*l?xK-PNG  IHDRryJzgAMA pHYsLLXtcPLTE#$ 84*&'"51;7.*?;2-2./+40)%(#,(=9950,+'=83.627383B>B?A=C?@=QNUQNJFBJFXU\Y^[DAZWIF]ZOKHDWSQMMJKHSOD@YUVSLISPFCYV[W^ZROLHOLWTb_`\a^b^`]iftrfc}pn|ymjxupmvtywc`li~{}{wt}{rogdvsda~{xuebnkkgkholtqheqnpnspzw{x~}ƵG'IDATx}|yNg˲$Dz6d[r^ 8&!iP*`Ԙ˒lbh^ZQ@!M#'MI4mt/kvӦMO$nwvgyfgwgt7<3(Z8˱!}t%O_dKU}*meDW܇lL7{]+>IcMC|l4IzO̚*Irìi.! gKz8T*%,佫X ˏ<&K$]vUtɑ,VEzIyH.#Ϛ!tifPIѳf$]Nfx$]F䜳fX$]>.fpHl]Κatg&o#K>k.8ietgƾUFI9|֌4&(D2I$ʴ[K\Co~$]YgȎ*FC$A#eY/c#"OFj+ <#۠1kZǮWM?f5$=Y!R+K.>k*qبPެM`$oY _&I1k̊/ 6/~"G̚J]Y͠E-%B$cJME.s`SϒrĬ9ö"^}2JOfdGʶ*Fwt%YSYw-V21 1y oU2l"lJK=G5ڠ}>i&{1kF%03%)Iy?|Tjzώ|vK{Áw돳L&)sI:i<";ZKܔ{< 5$1FT=twLW|^2? 6{) _%R;I1fI~3Dv F)+I3kFf4b[jNv)I3k* 5lc557{"bcfMsWz_&[lJ@E"̚ K,iM%]r̬IUlr̙p +颐cfM ߽٨Ɇ7t1QQai˿.9fdUll)] @5mB*ëN* tQ~͗26w_pS Iw5km{ޕCL3u B]!G͚,6gt9fִ: qsѪ”%(Y(iD TW#fMA$)/pY AA8z=CfMQ`J/{]MYS:Naq&(D08J;0tCfMQ@ "4\ҝfȶsidz?t;"G͚DtGaJJrܬs"paL IE5yBRlLB ͚.BSl鱊1;K;O9kz~"bsz s[QG#gMe~6iDjcLI!GΚ~ؤS\m%]Κ~$N#)}BܬQ`]j]|sa\Q#y0Y >/ <ʔ>&FzQœt/8EXlFt<ʔ_k=+= 071ox ɕpAqQj] *>~.6Q,tzM (Q_6\#frRLQB]uIRvpzM eۣ|mwJ63;VVX RԣLQ']iѧ3O޵ˍznq(ybE>)ΉFIX88S:U ,U3sdθT`"NBBonaEBORVV+x2j ' s%NR08E=ƓGVhbf#i+zbiӪ8SR"DKnb5rSWMu;6rH[!V#3S0Ow.Bd.A#[̕`XPg #ȂE#/93fZeɌ\S{<03Ol#4 2)J{d<=`[Sԗ ˀ\S%-x,-|@u=݅}55FJ77(\dcs'`}IIFKgnFmNڳw8B?Hz,s-ډ-}ֽ-V,a \954O|\*Kѹ\nW"ZO_^6MSa&y <07t|-s<7{<2*C6m,^YZ=@9Q(iE0b+ANlzQ~O9Q_\jVv^X !*y{F0DiR#ϲӓO5||@c|ȋA^Ɍ=t*"GIgPݙ-M> 9RP86uimڰJsp>/;|(|=i :\2noi@ Wߍ}kj qg@>a19i?K]~되>>7xlgߗ@g sh.~K|~ xs>"¹7U­Ůһ4vvg^i4so8xgkSdpG+'rmS}̈́ð)wh39jkku?ʒa@VfN6:%BwSTjc9u h5#p%k _=ANWvm)eͯlW+RuKw)]zYv})K-_%)kxb[nZ TVdxN~Uwjb;? bPVWȵ!|,<}qP ~9kZgL/g}lIV6z tNyPw\ܵ!1[gtwA[h%#N0y@d z|+C ŕ5G.Yn1<'`MMM7}dy(B#,yKg\7S;w²n r<0w :ҹ0)oux9֖~e⯖gs4[_Sۿ[ rf;G^8}EO{뢂G\Y/XId(Wp=Lh+ve7(so+}Gi'Mp_kk'KD74mфG-1 >cUƱe9 +5?r/:i@~D Gu݅fIZ`UEN 'D%=u\ 3A~ YoaEٷs7Dޠ_E8@-J1|s )rOAO.мE%!185<Ӧi_r`/qc/*!wR?̱+[=aǎ0{̱~}ee];Mf-nz1_W<o5O_cc>YF3>xפ@r.GΏcM]G}EuT)My+78ϻﵱ7Wa=U=_sYjr uK7xCuQ_?Yf n% ؜G-Y`n9 R9؆۳˔F„܀?mG^ {:Fߘ2C7CTk=\@pFk}j&'jv r5qC[:+@ުv߈MarCij BNԓ~P-w9j| 4E"G9 eljUc9!~sS̊PSFF:"YeSC\yHf GL2;6h3c&TiWyf|;tk$o59Yh{w{QȉJN,tΐH#\2*ّ$ʥ ~G0M}"'߇ǽ#FCx#;]vkr"']yVjMN\wn^ZǡWZ#Oo3w,J1G%EBOM_!X#ׯͦۡ"'rLQ5r})mx }M(%r3>QH}/yfN^܌ur"ȹOf5Z.\F|ߩch !~ kn*e#7vReUS8%!G~e`[pCheeAUsn+dz.~#GF3ܟ 9fu<' tW:H<:Kg I;N]:֜op?vԼ,Bkm܍VE8'w c$a_SPTVn58pi.7Ȋ|֜N)meX>wK*)07f^xz)G4w0oVjtP\RQ^so= PկMAwoIң_:û]ul#t0tHq}g:v.;'ѻ\^Vz9WʽRm5ݪ~yv N}Y!Pr&lj&(9f4@k|9!KE\oEqo*<#Z8kcu#QMe"w,:p/ė%"'W+S3'rN"Cr{\]^-P:~pOqL /r[+:@0#ֳ!9bb0,~[;|oB-l$rS't| !G4>ޱ ANg\RSVtDåZ-rTuif=˿1ȭ$K!O8f;`ŽsݦFvzozpWލ+++^=aG>@W2۱ή^=":۷{Eeu}sǂX>h#'Jg 3'U y>K ;rMyUQ v77- ?r*3arCޛ}u7^=n^n7]Vjz~T,PT|' %zo^ IL]" *^e6rg2OCy|l oPVmR rK?1f>B7pvk^77eT$r*gFE/AFj69iF= )N75u cy~iFƧ s|n14#kꑎ,EwA"^(m<x$|Drn=2P Wʻ Sp J<񉲋Jܔ3U=F/5>JtM"@4j|:@ !,rE/*քU5lώU}Mmy=wMu%{nA܇+ߒnzkݼhMBt#`+iyWw T?%EeM}'jӖb76f5`D<$Z $}7uQdk"%Z CrŃ⏤79#㦪5ǥDxOQEWaTnePu}?L(*hc^*R^QbEP/{ |%.#;f?d ?iKz $"l+is=x(J|kc.85`(hJ(l_sY^c%NQHiЕĶXĻCY#+=raDF+CBb~X?ĉx >< ptAwEԜӇjZRI7f. qmZ8CbeA!x%%p/ =K5Q$ݴkG\#^UC6I7rfU;o6n^6 _)ꊝeml 1vi,w.x4̉J.8IoIýlw'kmb JSQ>c釐<7 HһGGZSKG{WD{s{i\^6 <$=ߍq3htcS<W} 4|lMbϛvU*=8N1g,3{6]"Iqԋ[$|V'[g 4rgrH:X^6rWoqH8*n+t0E}hW f%&PQ U籤CE<L%.Iq`JmDCB*KHPJaJnHtH$A@$ ؞k=W[SOBi@B 0nfh*KHOJ PJQJ nHtHXS@X }'ckee,g)ۏ 37$8$G$H$^a$KHPJnHtH.. }'yblFhe,gCJaJlOl}'Char Char Char Chard1$CJKHPJaJmHnHu\O\ }'Default1$7$8$H$%B*CJ_HaJmH nHphsH tH6O6 }'Default1 B*ph,O, }'cke1 B*phBZ@B w=x~e,ga$CJOJPJQJ aJnHtHTOT w=x Char Char(CJKHOJPJQJ _HmH nHsH tH`` q[Q{>ʑ0t qstuv#$FGH  <=|}STh i % & MN89{|RSmn Z[CDn o """".#/#^#_#v#w#####$$i%j%x%y%&&&&&&&&&&&&&&'''''&'''('z'{'''( (6(7((())))**4+5+++k,l,q-r---\/]///e1f111*2+222J3K3Z3[3334445464>4?4P4Q4R4m4n4555555666666w7x7y7777777777&8'888888+9,9<999999999:::::/:0:N:O:8;9;:;I;J;r;s;;;;;;;<<<<<<===-=.=i=j======== > > >&>5>@>M>N>O>P>R>S>U>V>X>Y>[>\>]>^>i>j>k>v>w>x>{>0 00000000000000000000000000000000000 0 00000000000000000000000000' 00' 0000( 00( 00( 000000000000000000000000000000 00 0000000 00 00 00 0 0 0 0 0 0 00 00 000% 00% 00000$ 00$ 00$ 0!00000000000008002202020202002020202020202020202020202 02020202020202020202 02 02 0202 02 02020202020202 020202020202 02 0202 02 02 02 0202 02 02 0202 02 02 0202 02 0202 02 02 0202 0202 02 0202 02 02 02 0202 02 0202 0202 02 0000202020202020202020202 0202020202 02 02020202 02 02 0@0ȑ0F@0ȑ0F@0ȑ0F@0ȑ0F@0@0@0@0@0@0@0@0ȑ0Fqstuv#$FGH  <=|}STh i % & MN89{|RSmn Z[CDn o """".#/#^#_#v#w#####$$i%j%x%y%&&&&&&&&&&&&&&'''''&'''('z'{'''( (6(7((())))**4+5+++k,l,q--\/]///e1f111*2555666666w7x7y7888+9,9<999999::/:0:9;:;r;s;;;;;;<<<<<===-= > >N>O>{>0000000000000000000000000000000000000 00000000000000000000000000' 00' 0000( 00( 00( 000000000000000000000000000000 00 0000000 00 00 00 0 0 0 0 0 0 00 00 000% 00% 00000$ 00$ 00$ 0ȑ0ʑ0ȑ0ԩkȑ0ȑ0ȑ0ʑ0ȑ0ȑ0ʑ0ʑ0kȑ0ȑ0ȑ0ʑ0ȑ0  ȑ0ʑ0ȑ0 ʑ0xkȑ0ȑ0ȑ0ȑ0ʑ0ȑ0 ȑ0tkȑ0ȑ0kȑ0ȑ0kȑ0ȑ0kȑ0ȑ0Tkȑ0ȑ0ȑ0ȑ0ȑ0ʑ0ȑ0 ʑ0ʑ0ȑ0ȑ0D ȑ0|  (((+ :Nei&o "$v'(*n,-o.0012j356v8?;i< >?CF1$'(*+,-.0234679:;=>?ABDGIKLMOPQSUXacf-[v#)X.W111B2N4$:>NCDFWGGAHB%)/158<@CEFHJNRTVWYZ_`bdeg&"$+!!  ,b$l?xK-}*3# AA@ (  J  C A?B S  ?H0(  qz>xPt_GoBack({>({>$d䏦  d $ 䎦  d L T̬ eb $J !Կ"Tʙ #ʙ $,%| &d' ( )q *$ +ԏ 9"""#%#%#E#K#K#x)~)~)B/111@4F4F4S4Y4Y499#=#={>    <"""$#-#-#J#S#S#})))E/111E4N4N4X4a4a499'='={> 8*urn:schemas-microsoft-com:office:smarttagsCity<*urn:schemas-microsoft-com:office:smarttagschmetcnv9*urn:schemas-microsoft-com:office:smarttagsplaceB*urn:schemas-microsoft-com:office:smarttagscountry-region9*urn:schemas-microsoft-com:office:smarttagsState X4z 0114aFalseHasSpaceNegative NumberType SourceValueTCSCUnitName      v*19@W^W^,3 JQ%,bi:;Y`18.5sz-4(/^els  !!9#@###d2p233"4)444 55>5E55566-87898>899;:B:c:j::;$;+;;;===========>*>->.>4>9>;>P>P>R>R>S>S>U>V>X>Y>[>\>x>{>vS[9;z # 9#@#''((++//556v7'88;<P>P>R>R>S>S>U>V>X>Y>[>\>x>{>33333333333G_#w#j%y%&(' (7(R4n4667788,9<99999::0:O::;J;s;;;;<<=.===P>P>R>R>S>S>U>V>X>Y>[>\>h>i>x>{>P>P>R>R>S>S>U>V>X>Y>[>\>x>{>(>k/0h{c  uo+ :%M bU^X.` KP $Y[T^T3j s/?!c0 $%̛P& Q.'FFk4C41e$M8NyeW:Xi9AT~ZALldDNtT&_[Fd\I\FGKLjE|Lb7Q 'C U8CYR-J^sB`6sRdzke$M8 TiT3j Y[{c 7Q:%M E|Lmw-J^//?!ukxQ.'sRdi9A\IwoB`yeW:P& $%dDZAKP vW~GK&_[Fo+ Zs8f((%        Zn       r        Z)        f#h        ’                         x0>b*       oTԚ=      Gi                          f:Ob|       &"N                 :        g0       H{*       UPe       b        D        ,:        J         Lr        f6                          X"        tX        H        J                  Jmwld      6N        }`        *        ܞ        4         e        t2+WHEZho(UCC,3k "}'n+\, f/}X0qE3}6~76=?AC2FeM\O0O.8OVPjTsZO[{V\ ]K]Y*^._`bEebiqj@j^kj\o4/qNrSZrw=xbxY~|q[ kn8/B>~aPa4T ib:T*x_Fw@O|(kTts}!"dcS@a/PLyHtfX^PH+f7Arc%,@Yh 1FG"&&&&&'''''&'''133n4666x7y77888+9,9<9999999:::/:0:O:9;:;J;r;s;;;;;<<<i=j== > >M>N>O>{>7#&3/=@lvv99959697981:;<z>`@` `@``@@`@`B`D`@`p@``x@Unknown Gz Times New Roman5Symbol3& z ArialKM  DFKai-SBPMingLiUUSimSunTimes New Roman;[SOSimSunC .PMingLiUe0}fԚ[TimesLTStd-RomanPMingLiU] Times-BoldTimes New RomanQ MSung-LightPMingLiU_ Times-RomanTimes New Roman?5 z Courier New 1h**'*'L 5qL 5q!?!%),.:;>?]}    & 0 2 3 : !6"000 0 00000006:>@DZ\^ =@\]^$([{  0 0 000000Y[];[d1>1>2HX?sZ2~The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representationANDYLAWhggSf(                           ! " # $ % & ' Oh+'0 ,<HX ht   The Stock Exchange of Hong Kong Limited takes no responsibility for the contents of this announcement, makes no representationANDYLAWNormal18Microsoft Office Word@2~@ @27HQ@RPL 5՜.+,0 X`t|  Charltonsq1>'   !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}Root Entry FjData ~1TableWordDocumentSummaryInformation(DocumentSummaryInformation8CompObjm  FMicrosoft Office Word ĵ MSWordDocWord.Document.89q